title: A phosphorimager-based filter binding thyroid hormone receptor competition assay for chemical screening.
abstract: BACKGROUND
  A phosphorimager-based filter binding thyroid hormone receptor (THR) competition assay has been developed for use in verifying hits from compound library screens.
  
  
  METHODS
  This method employs in vitro translated ligand binding domains (LBDs) of THRalpha and THRbeta, separation through nitrocellulose via a 96-well vacuum manifold, and analysis of receptor-bound radioactivity by phosphorimaging.
  
  
  RESULTS
  A standard curve of [I(125)]T3 showed a linear response over the dynamic range of a competition assay, and a comparison of Sephadex G-25 column separation and gamma counting with en masse filtration and phosphorimaging revealed similar IC(50) and K(i) values when using unlabeled T3 as competitor. In addition, this method produced IC(50) and K(i) values for the known T3 competitors [3,5-Dimethyl-4-(4'-hydoxy-3'-isopropylbenzyl) phenoxy] acetic acid (GC-1) and 3,5-diiodothyropropionic acid (DITPA) similar to those reported elsewhere.
  
  
  CONCLUSIONS
  These data suggest that filtration and phosphorimaging adequately and properly reproduces binding values associated with THR competition. Further, this method gave a 3-fold reduction in time and a 40-fold reduction in radioactive waste over the column-based method. These reductions allow for a substantial increase in assay throughput. Taken together, these data suggest that en masse filtration and phosphorimaging is an efficient and tractable method for verifying large groups of putative T3 competitors in vitro.
authors.affiliation: Molecular Pharmacology, Myogen, Inc., Westminster, CO 80021, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Chapo
authors.forename: Yanyu
authors.initials: Y
authors.lastname: Peng
authors.forename: Kelly R
authors.initials: KR
authors.lastname: Pitts
mesh_terms: D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D002850:Chromatography, Gel; D004104:Diiodothyronines / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D010636:Phenols / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D011817:Rabbits; D011869:Radioligand Assay / Q000379:methods; D011994:Recombinant Proteins / Q000378:metabolism; D037021:Thyroid Hormone Receptors alpha / Q000378:metabolism*; D037042:Thyroid Hormone Receptors beta / Q000378:metabolism*; D014284:Triiodothyronine / Q000378:metabolism*
chemical_list: D000085:Acetates; D004104:Diiodothyronines; C413355:GC 1 compound; D010636:Phenols; D011422:Propionates; D011994:Recombinant Proteins; D037021:Thyroid Hormone Receptors alpha; D037042:Thyroid Hormone Receptors beta; D014284:Triiodothyronine; C082182:3,5-diiodothyropropionic acid